The Claudin-low subtype has been described as BC entity [8,48], which is enriched for ER-negative invasive ductal carcinomas, while displaying low levels of luminal differentiation markers and activation of pathways involved in epithelial-to-mesenchymal transition, stem cell-like features and the immune response [8]. Here, ESR1 is linked to invasive ductal breast carcinoma.